An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT00052052 · COMPLETED
Trial details
- NCT number
- NCT00052052
- Sponsor
- InterMune
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.